Summary
Latest filing:
Neal Franklin Fowler is Director of Emergent BioSolutions Inc. (EBS). 1 SEC Form 4 filing on record, dated 4 May 2026.
Recent transactions
1The latest SEC Form 4 transaction reported by Neal Franklin Fowler.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Neal Franklin Fowler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Donald W. Degolyer - $318K in EBS purchases and sales in the last 12 months
- Coleen Glessner - $306K in EBS purchases and sales in the last 12 months
- Sujata Tyagi Dayal - $201K in EBS purchases and sales in the last 12 months
- Kathryn C. Zoon - $144K in EBS purchases and sales in the last 12 months
- Keith Katkin - $128K in EBS purchases and sales in the last 12 months
- Paul Anthony Williams - $59K in EBS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Neal Franklin Fowler?
Neal Franklin Fowler is a corporate insider, tracked as Director of Emergent BioSolutions Inc. (EBS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Neal Franklin Fowler last file a Form 4?
The only primary Form 4 on record is dated 4 May 2026.
